# Efficacy of a New Delivery System for Beta-hydroxy-beta-methylbutyrate

> **NCT01150526** · PHASE1 · COMPLETED · sponsor: **Metabolic Technologies Inc.** · enrollment: 41 (actual)

## Conditions studied

- Healthy

## Interventions

- **DIETARY_SUPPLEMENT:** CaHMB
- **DIETARY_SUPPLEMENT:** HMB Free Acid Gel
- **DIETARY_SUPPLEMENT:** Placebo
- **DIETARY_SUPPLEMENT:** Placebo Gel Dosage

## Key facts

- **NCT ID:** NCT01150526
- **Lead sponsor:** Metabolic Technologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2010-11
- **Final completion:** 2012-07
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2012-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01150526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01150526, "Efficacy of a New Delivery System for Beta-hydroxy-beta-methylbutyrate". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01150526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*